CD4 and neoplasm: At first, DC vaccination protocols mainly focused on targeting cytotoxic CD8+ T cells, but it has become clear that CD4+ T cells not only augment the induction and proliferation of these CD8+ T cells, but also participate in the elimination of tumor cells and maintenance of long-term immunity.